Implant-associated local drug delivery systems based on biodegradable polymers: customized designs for different medical applications

References

[1] Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006; 58: 387–401.10.1016/j.addr.2006.01.016Suche in Google Scholar

[2] Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int 2005; 54: 36–46.10.1002/pi.1697Suche in Google Scholar

[3] Andreopoulos AG. Plasticization of biodegradable polymers for use in controlled release. Clin Mater 1994; 15: 89–92.10.1016/0267-6605(94)90074-4Suche in Google Scholar

[4] Banai S, Chorny M, Gertz SD, et al. Locally delivered nanoencapsulated Tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 2005; 26: 451–461.10.1016/j.biomaterials.2004.02.040Suche in Google Scholar

[5] Bangham AD. Liposomes: the Babraham connection. Chem Phys Lipids 1993; 64: 275–285.10.1016/0009-3084(93)90071-ASuche in Google Scholar

[6] Bhargava B, Reddy NK, Karthikeyan G, et al. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model. Catheter Cardiovasc Interv 2006; 67: 698–702.10.1002/ccd.20698Suche in Google Scholar PubMed

[7] Bohl A, Rohm HW, Ceschi P, et al. Development of a specially tailored local drug delivery system for the prevention of fibrosis after insertion of cochlear implants into the inner ear. J Mater Sci Mater Med 2012; 23: 2151–2162.10.1007/s10856-012-4698-zSuche in Google Scholar PubMed

[8] Bünger CM, Grabow N, Kröger C, et al. Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J Endovasc Ther 2006; 13: 630–639.10.1583/06-1899R.1Suche in Google Scholar PubMed

[9] Bünger CM, Grabow N, Sternberg K, et al. Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J Surg Res 2007; 139: 77–82.10.1016/j.jss.2006.07.035Suche in Google Scholar PubMed

[10] Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL Jr. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther 2002; 1: 197–204.Suche in Google Scholar

[11] Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496–501.10.1056/NEJM199408253310802Suche in Google Scholar PubMed

[12] Freier T, Kunze C, Nischan C, et al. In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate). Biomaterials 2002; 23: 2649–2657.10.1016/S0142-9612(01)00405-7Suche in Google Scholar

[13] Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol 2010; 56: S1–S42.10.1016/j.jacc.2010.06.007Suche in Google Scholar PubMed

[14] Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol 2010; 56: S43–S78.10.1016/j.jacc.2010.06.008Suche in Google Scholar PubMed

[15] Goddard JM, Hotchkiss JH. Polymer surface modification for the attachment of bioactive compounds. Prog Polym Sci 2007; 32: 698–725.10.1016/j.progpolymsci.2007.04.002Suche in Google Scholar

[16] Grabow N, Martin DP, Schmitz K-P, Sternberg K. Absorbable polymer stent technologies for vascular regeneration. J Chem Technol Biotechnol 2010; 85: 744–751.10.1002/jctb.2282Suche in Google Scholar

[17] Grabow N, Schlun M, Sternberg K, Hakansson N, Kramer S, Schmitz K-P. Mechanical properties of laser cut poly(L-lactide) micro-specimens: implications for stent design, manufacture, and sterilization. J Biomech Eng 2005; 127: 25–31.10.1115/1.1835349Suche in Google Scholar PubMed

[18] Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61–68.10.1056/NEJM197907123010201Suche in Google Scholar PubMed

[19] Gümüşderelioglu M, Deniz G. Sustained release of mitomycin-C from poly(DL-lactide)/poly(DL-lactide-co-glycolide) films. J Biomater Sci Polym Ed 2000; 11: 1039–1050.10.1163/156856200743562Suche in Google Scholar PubMed

[20] Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006; 27: 564–569.Suche in Google Scholar

[21] Hawkins MJ, Soon-Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 2008; 60: 876–885.10.1016/j.addr.2007.08.044Suche in Google Scholar PubMed

[22] Jedlinski Z, Kowalczuk M, Glowkowski W, Grobelny J, Szwarc M. Novel polymerization of b-butyrolactone initiated by potassium naphthalenide in the presence of a crown ether or a cryptand. Macromolecules 1991; 24: 349–352.10.1021/ma00002a002Suche in Google Scholar

[23] Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193–202.10.1016/j.jacc.2006.03.042Suche in Google Scholar

[24] Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir 2005; 21: 8852–8857.10.1021/la0502084Suche in Google Scholar

[25] Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198–3206.10.1161/CIRCULATIONAHA.108.826479Suche in Google Scholar

[26] Kober T, König I, Weber M, Kojda G. Diethyldithiocarbamate inhibits the catalytic activity of xanthine oxidase. FEBS Lett 2003; 551: 99–103.10.1016/S0014-5793(03)00876-7Suche in Google Scholar

[27] Lanzer P, Sternberg K, Schmitz KP, Kolodgie F, Nakazawa G, Virmani R. Drug-eluting coronary stent very late thrombosis revisited. Herz 2008; 33: 334–342.10.1007/s00059-008-3080-xSuche in Google Scholar

[28] Lendlein A. Polymere als Implantatwerkstoffe. Chem Unserer Zeit 1999; 33: 279–295.10.1002/ciuz.19990330505Suche in Google Scholar

[29] Lipsky JJ, Shen ML, Naylor S. Overview – in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chem Biol Interact 2001; 130–132: 81–91.10.1016/S0009-2797(00)00224-6Suche in Google Scholar

[30] Löbler M, Sternberg K, Stachs O, et al. Polymers and drugs suitable for the development of a drug delivery drainage system in glaucoma surgery. J Biomed Mater Res B Appl Biomater 2011; 97: 388–395.10.1002/jbm.b.31826Suche in Google Scholar PubMed

[31] Luderer F, Begerow I, Schmidt W, et al Enhanced visualization of biodegradable polymeric vascular scaffolds by incorporation of gold, silver and magnetite nanoparticles. J Biomater Appl 2012 [Epub ahead of print].10.1177/0885328212443393Suche in Google Scholar PubMed

[32] Luderer F, Löbler M, Rohm HW, et al. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application. J Biomater Appl 2011; 25: 851–875.10.1177/0885328209360696Suche in Google Scholar PubMed

[33] Marks AR. Cellular functions of immunophilins. Physiol Rev 1996; 76: 631–649.10.1152/physrev.1996.76.3.631Suche in Google Scholar

[34] Martin DP, Williams SF. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial. Biochem Eng J 2003; 16: 97–105.10.1016/S1369-703X(03)00040-8Suche in Google Scholar

[35] Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995; 76: 412–417.10.1161/01.RES.76.3.412Suche in Google Scholar

[36] Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387–6392.Suche in Google Scholar

[37] Meiser BM, Morris RE, Billingham ME. Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet 1991; 338: 1297–1298.10.1016/0140-6736(91)92594-RSuche in Google Scholar

[38] Minelli C, Lowe SB, Stevens MM. Engineering nanocomposite materials for cancer therapy. Small 2010; 6: 2336–2357.10.1002/smll.201000523Suche in Google Scholar

[39] Miyata T, Asami N, Uragami T. A reversibly antigen-responsive hydrogel. Nature 1999; 399: 766–769.10.1038/21619Suche in Google Scholar

[40] Miyata T, Asami N, Uragami T. Structural design of stimuli-responsive bioconjugated hydrogels that respond to a target antigen. J Polym Sci B Polymer Phys 2009; 47: 2144–2157.10.1002/polb.21812Suche in Google Scholar

[41] Moellering D, McAndrew J, Jo H, Darley-Usmar VM. Effects of pyrrolidine dithiocarbamate on endothelial cells: protection against oxidative stress. Free Radic Biol Med 1999; 26: 1138–1145.10.1016/S0891-5849(98)00300-1Suche in Google Scholar

[42] Mohacsi PJ, Tüller D, Hulliger B, Wijngaard PL. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. J Heart Lung Transplant 1997; 16: 484–492.Suche in Google Scholar

[43] Moon JI, Kim YS, Kim MS, et al. Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study. Transplant Proc 2000; 32: 2026–2027.10.1016/S0041-1345(00)01542-6Suche in Google Scholar

[44] Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–1780.10.1056/NEJMoa012843Suche in Google Scholar PubMed

[45] Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175–181.10.1016/j.jacc.2005.07.071Suche in Google Scholar PubMed

[46] Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98: 2277–2283.10.1172/JCI119038Suche in Google Scholar PubMed PubMed Central

[47] Regar E, Sianos G, Serruys PW. Stent development and local drug delivery. Br Med Bull 2001; 59: 227–248.10.1093/bmb/59.1.227Suche in Google Scholar PubMed

[48] Schultz D, Skamarauskas JT, Law N, Mitchinson MJ, Hunt JV. The inhibition of foam cell formation by sodium diethyldithiocarbamate. Free Radic Res 1995; 23: 259–271.10.3109/10715769509064039Suche in Google Scholar PubMed

[49] Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489–495.10.1056/NEJM199408253310801Suche in Google Scholar PubMed

[50] Shian S-G, Kao Y-R, Wu FY-H, Wu C-W. Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol 2003; 64: 1076–1084.10.1124/mol.64.5.1076Suche in Google Scholar PubMed

[51] Sternberg K, Kramer S, Nischan C, et al. In vitro study of drug-eluting stent coatings based on poly(l-lactide) incorporating cyclosporine A – drug release, polymer degradation and mechanical integrity. J Mater Sci Mater Med 2007; 18: 1423–1432.10.1007/s10856-007-0148-8Suche in Google Scholar PubMed

[52] Sternberg K, Petersen S, Grabow N, et al. Implant-associated local drug delivery systems for different medical applications. Biomed Tech (Berl) 2012; 57(Suppl. 1): 393–396.10.1515/bmt-2012-4473Suche in Google Scholar

[53] Stoltenberg RL, Geraghty J, Steele DM, Kennedy E, Hullett DA, Sollinger HW. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine. Transplantation 1995; 60: 993–998.10.1097/00007890-199511150-00020Suche in Google Scholar

[54] Taylor RD, Maners AW, Salari H, Baker M, Walker EM Jr. Disulfiram as a radiation modifier. Ann Clin Lab Sci 1986; 16: 443–449.Suche in Google Scholar

[55] Van de Water TR, Dinh CT, Vivero R, et al. Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic. Acta Otolaryngol 2010; 130: 308–311.10.3109/00016480903124655Suche in Google Scholar

[56] Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med 2012; 63: 185–198.10.1146/annurev-med-040210-162544Suche in Google Scholar PubMed

[57] Wang W, McLeod HL, Cassidy J. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer 2003; 104: 504–511.10.1002/ijc.10972Suche in Google Scholar PubMed

[58] Wulf K, Teske M, Löbler M, Luderer F, Schmitz K-P, Sternberg K. Surface functionalization of poly(ε-caprolactone) improves its biocompatibility as scaffold material for bioartificial vessel prostheses. J Biomed Mater Res B Appl Biomater 2011; 98B: 89–100.10.1002/jbm.b.31836Suche in Google Scholar PubMed

[59] Yilmaz B, Cetin M, Palabiyik SS, Asci A. HPLC method for determination of disulfiram in pharmaceutical preparations. Alfa Univ Int J Chem 2010; 1: 79–86.Suche in Google Scholar